Literature DB >> 2447414

Similarity and dissimilarity in the mode and mechanism of action between nicorandil and classical nitrates: an overview.

N Taira1.   

Abstract

Nicorandil, which is structurally a nitrate and also a nicotinamide, differs from classical nitrates such as nitroglycerin and isosorbide dinitrate in the following respects. It dilates preferentially resistive vessels (arterioles); and it produces the increase in potassium conductance in the membranes of cardiac and some vascular smooth muscle cells that is responsible for its negative inotropic and chronotropic and vasodilator effects. Nicorandil has the following characteristics of a nitrate. (a) It is capable of dilating large conductive coronary arteries, although the effect is weaker than that of classical nitrates. (b) It is capable of reducing venous return, although this effect is less pronounced than that of classical nitrates. (c) It produces an increase in intracellular cyclic guanosine-3',5'-monophosphate (cyclic GMP) in vascular smooth muscle. The activity of nicorandil to increase the membrane potassium conductance resides in the nicotinamide moiety. However, this activity is greatly enhanced by the presence of the nitrate group at an appropriate distance from the nicotinamide group. The nitrate moiety per se has also its own action. The presence of these two pharmacologically active groups in the molecule appears to cause nicorandil to have rather complex cardiovascular actions.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2447414

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  32 in total

1.  Impact of nicorandil in angina: subgroup analyses.

Authors: 
Journal:  Heart       Date:  2004-12       Impact factor: 5.994

2.  Role of nicotinic acid and nicotinamide in nicorandil-induced ulcerations: from hypothesis to demonstration.

Authors:  Philippe Trechot; Jean-Yves Jouzeau; Clotilde Brouillard; Julien Scala-Bertola; Nadine Petitpain; Jean-François Cuny; Guillaume Gauchotte; Jean-Luc Schmutz; Annick Barbaud
Journal:  Int Wound J       Date:  2013-09-13       Impact factor: 3.315

Review 3.  Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction.

Authors:  Vijayalakshmi Kunadian; Cafer Zorkun; Scott P Williams; Leah H Biller; Alexandra M Palmer; Katherine J Ogando; Michelle E Lew; Navin Nethala; William J Gibson; Susan J Marble; Jacqueline L Buros; C Michael Gibson
Journal:  J Thromb Thrombolysis       Date:  2008-09-26       Impact factor: 2.300

4.  T-1583 and forskolin are similar in their cardiac effects and dissimilar in their vascular effects.

Authors:  M Hosono; K Satoh; N Taira
Journal:  Cardiovasc Drugs Ther       Date:  1988-07       Impact factor: 3.727

5.  Nicorandil induces late preconditioning against myocardial infarction in conscious rabbits.

Authors:  Xian-Liang Tang; Yu-Ting Xuan; Yanqing Zhu; Gregg Shirk; Roberto Bolli
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-12-18       Impact factor: 4.733

6.  Effects of KRN2391, nicorandil and diltiazem on the changes in the electrocardiogram caused by endothelin-1 in anaesthetized rats.

Authors:  K Harada; A Miwa; S Kaneta; T Izawa; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

7.  Double-blind comparison of the acute effects of two relevant doses of oral nicorandil on central hemodynamics, left ventricular function, and myocardial contractility.

Authors:  A Baumbach; U Braun; G Döring; K K Haase; W Voelker; K R Karsch
Journal:  Cardiovasc Drugs Ther       Date:  1995-03       Impact factor: 3.727

8.  Identification and properties of an ATP-sensitive K+ current in rabbit sino-atrial node pacemaker cells.

Authors:  X Han; P E Light; W R Giles; R J French
Journal:  J Physiol       Date:  1996-01-15       Impact factor: 5.182

9.  Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.

Authors:  I Nakae; L Quan; K Hashimoto; Y Sugimoto; T Tsutamoto; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

10.  In vitro protective effects of nicorandil on hypothermic injury to immature cardiac myocytes: comparison with nitroglycerin.

Authors:  H Orita; M Fukasawa; S Hirooka; K Fukui; M Kohi; M Washio
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.